Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.
about
A literature review and survey of childhood pneumonia etiology studies: 2000-2010Indole trimers with antibacterial activity against Gram-positive organisms produced using combinatorial biocatalysisLong-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalisUse of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsPSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts.Rifampin use and safety in hospitalized infants.Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitisCommunity-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.Incidence and predisposing factors of vancomycin-induced nephrotoxicity in childrenPediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantationAnimal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean childrenComparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal InsufficiencyOpsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children.Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrugAssociation of neighborhood-level factors with hospitalization for community-associated methicillin-resistant Staphylococcus aureus, New York City, 2006: a multilevel observational study.Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolidTrends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulationBacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection.The Mechanism Underlying the Antibacterial Activity of Shikonin against Methicillin-Resistant Staphylococcus aureus.Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001-2010.Prevention of Recurrent Staphylococcal Skin InfectionsOutcomes of laparoscopic versus open fundoplication in children's hospitals: 2005-2008.No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates.Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbitsBurden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.Trends in adverse reactions to trimethoprim-sulfamethoxazoleStaphylococcal infections in children, California, USA, 1985-2009Trends in resource utilization for hospitalized children with skin and soft tissue infections.Improved vancomycin dosing in children using area under the curve exposure.Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease?Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012.The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system.A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis.Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
P2860
Q27009029-A64A6CE1-D1F8-4079-B44C-26DBD66F822FQ28397152-80DC12F5-6E0F-46C5-97A1-9F85575C9F53Q28728017-27269A8E-9B03-48CC-9123-FCB12CAC53DBQ30832465-D5A19CC3-5D10-405A-887F-9260CC1BA1D8Q31117779-2D44EA3D-5332-498C-B4F0-704F7D4181F7Q33419821-5183B157-DA0B-4EED-86DE-0E83B0DBEB2BQ33506628-6D183BDB-7CDC-47E3-865A-3E2693502795Q33897606-F0A316C3-FBB7-452C-84FC-EE1A6505B5AEQ33939018-7C6274EE-CB6D-4847-ABD5-B772B5581917Q34051146-013236FD-3106-46D9-9830-44939EE8917DQ34090161-A73FCA36-8E43-4E87-9440-D525C2CABAABQ34146127-A5D02AC0-3685-4B51-81D1-39EAC7B0E913Q34150985-55A877A8-028E-4BE7-A2B1-9D8E4C99A0C9Q34314798-486CE348-F37A-4B1C-A9B0-D27DA5CC7272Q34450382-B3A36E09-9D8A-4CFD-B951-55973D20AE0BQ34520680-03D60DCF-875B-4ADA-BF04-FF3E39EB34B5Q34548251-962283D3-DEF2-47F7-85E4-D169EED0E07BQ34584922-098E0EFE-43FF-4B70-9824-F5089D377516Q34658779-233B3BFE-CA74-4C1F-8765-ECD27DB0AE1FQ34773922-746E303E-D10B-4FCD-A67F-401EF47A2A15Q34989352-C2F00B14-7B77-4FC2-9F61-D0B1AF3BBEE7Q35873349-EF6FCD4C-C112-4C7D-8D24-EE50667790C0Q35912802-DA766A1B-A988-4032-8BA6-928E6BA2B71CQ35980009-D8B67A95-98F5-4F97-B240-4F5D76E9375DQ36005464-0FF2D54A-E5FF-4B31-9200-551E929F21CBQ36071098-941845AC-EF76-44E8-BC39-9E0C73809007Q36169980-FA01B746-A685-428B-981E-7785DA1E1A7EQ36274561-E1E2E34E-84AF-4DB2-B94F-C489564A7E42Q36396110-FE49EF7A-3FD8-4569-B397-4A1437F0B37AQ36396146-C815B99D-C879-45F4-8AC6-14325F4E6FD7Q36411049-F7E75BDE-17A1-435D-A539-76AA12C1D712Q36487908-71377BBE-72EA-4B45-B867-197176E445CDQ36570814-48F505E2-6AAB-4975-B6A1-726863DA9177Q36637095-0E9375F0-9831-484E-95D7-F6C9E1012BA1Q36784672-238EBA4B-A79F-40A4-93A5-5D9BFB92488FQ36873127-74EA9588-AEE3-44AB-AB82-7C4EC802AC09Q37016425-EB275DE6-6568-4D2E-90BE-4A049FC6246CQ37024632-FE07A836-B12D-4066-B092-F64D67B808B8Q37042073-6579BCBD-5E72-4D5A-854B-EE36AFCF4B15Q37055102-0EDCF687-E25C-41E9-ADF1-9F44E65D9C2C
P2860
Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Trends in the incidence of met ...... ospitals in the United States.
@ast
Trends in the incidence of met ...... ospitals in the United States.
@en
type
label
Trends in the incidence of met ...... ospitals in the United States.
@ast
Trends in the incidence of met ...... ospitals in the United States.
@en
prefLabel
Trends in the incidence of met ...... ospitals in the United States.
@ast
Trends in the incidence of met ...... ospitals in the United States.
@en
P2093
P2860
P356
P1476
Trends in the incidence of met ...... ospitals in the United States.
@en
P2093
Jeffrey S Gerber
Sarah A Smathers
Susan E Coffin
Theoklis E Zaoutis
P2860
P356
10.1086/599348
P407
P577
2009-07-01T00:00:00Z